Literature DB >> 22750144

Exogenous and endogenous ghrelin counteracts GLP-1 action to stimulate cAMP signaling and insulin secretion in islet β-cells.

Boldbaatar Damdindorj1, Katsuya Dezaki, Tomoyuki Kurashina, Hideyuki Sone, Rauza Rita, Masafumi Kakei, Toshihiko Yada.   

Abstract

We studied interactive effects of insulinotropic GLP-1 and insulinostatic ghrelin on rat pancreatic islets. GLP-1 potentiated glucose-induced insulin release and cAMP production in isolated islets and [Ca(2+)](i) increases in single β-cells, and these potentiations were attenuated by ghrelin. Ghrelin suppressed [Ca(2+)](i) responses to an adenylate cyclase activator forskolin. Moreover, GLP-1-induced insulin release and cAMP production were markedly enhanced by [D-lys(3)]-GHRP-6, a ghrelin receptor antagonist, in isolated islets. These results indicate that both exogenous and endogenous islet-derived ghrelin counteracts glucose-dependent GLP-1 action to increase cAMP production, [Ca(2+)](i) and insulin release in islet β-cells, positioning ghrelin as a modulator of insulinotropic GLP-1.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22750144     DOI: 10.1016/j.febslet.2012.06.034

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  15 in total

Review 1.  Glucagon-like peptide 1 interacts with ghrelin and leptin to regulate glucose metabolism and food intake through vagal afferent neuron signaling.

Authors:  Charlotte C Ronveaux; Daniel Tomé; Helen E Raybould
Journal:  J Nutr       Date:  2015-02-04       Impact factor: 4.798

Review 2.  Involvement of thermosensitive TRP channels in energy metabolism.

Authors:  Kunitoshi Uchida; Katsuya Dezaki; Takeshi Yoneshiro; Tatsuo Watanabe; Jun Yamazaki; Masayuki Saito; Toshihiko Yada; Makoto Tominaga; Yusaku Iwasaki
Journal:  J Physiol Sci       Date:  2017-06-27       Impact factor: 2.781

3.  Incretin dysfunction and hyperglycemia in cystic fibrosis: Role of acyl-ghrelin.

Authors:  Xingshen Sun; Yaling Yi; Bo Liang; Yu Yang; Nan He; Katie Larson Ode; Aliye Uc; Kai Wang; Katherine N Gibson-Corley; John F Engelhardt; Andrew W Norris
Journal:  J Cyst Fibros       Date:  2019-02-07       Impact factor: 5.482

4.  Pharmacokinetics and pharmacodynamics of PF-05190457: The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.

Authors:  William S Denney; Gabriele E Sonnenberg; Santos Carvajal-Gonzalez; Theresa Tuthill; V Margaret Jackson
Journal:  Br J Clin Pharmacol       Date:  2016-10-29       Impact factor: 4.335

5.  Glucagon-like peptide-1 potentiates glucose-stimulated insulin secretion via the transient receptor potential melastatin 2 channel.

Authors:  Bo Pang; Sungjoon Kim; Daiqing Li; Zejun Ma; Bei Sun; Xiaona Zhang; Zhongming Wu; Liming Chen
Journal:  Exp Ther Med       Date:  2017-09-19       Impact factor: 2.447

6.  Pharmacological characterization of the first in class clinical candidate PF-05190457: a selective ghrelin receptor competitive antagonist with inverse agonism that increases vagal afferent firing and glucose-dependent insulin secretion ex vivo.

Authors:  J Kong; J Chuddy; I A Stock; P M Loria; S V Straub; C Vage; K O Cameron; S K Bhattacharya; K Lapham; K F McClure; Y Zhang; V M Jackson
Journal:  Br J Pharmacol       Date:  2016-03-17       Impact factor: 8.739

Review 7.  Modulation of pancreatic exocrine and endocrine secretion.

Authors:  Rashmi Chandra; Rodger A Liddle
Journal:  Curr Opin Gastroenterol       Date:  2013-09       Impact factor: 3.287

8.  Improved acylated ghrelin suppression at 2 years in obese patients with type 2 diabetes: effects of bariatric surgery vs standard medical therapy.

Authors:  S K Malin; A Samat; K Wolski; B Abood; C E Pothier; D L Bhatt; S Nissen; S A Brethauer; P R Schauer; J P Kirwan; S R Kashyap
Journal:  Int J Obes (Lond)       Date:  2013-10-29       Impact factor: 5.095

9.  Pancreas is a preeminent source of ghrelin after sleeve gastrectomy in Wistar rats.

Authors:  Alonso Camacho-Ramírez; María Ángeles Mayo-Ossorio; José Manuel Pacheco-García; David Almorza-Gomar; Antonio Ribelles-García; Ana Belmonte-Núñez; J Arturo Prada-Oliveira; Gonzalo M Pérez-Arana
Journal:  Histol Histopathol       Date:  2020-01-17       Impact factor: 2.303

Review 10.  Gastrointestinal dopamine as an anti-incretin and its possible role in bypass surgery as therapy for type 2 diabetes with associated obesity.

Authors:  Suleman Chaudhry; Marilia Bernardes; Paul E Harris; Antonella Maffei
Journal:  Minerva Endocrinol       Date:  2015-10-27       Impact factor: 2.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.